Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.34 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17393310 | 1.00 | TSHR (0.47) | TSHRCA1CA2CA4LMNA | |
| SCHEMBL17393428 | 1.00 | TSHR (0.47) | TSHRCA1CA2CA4LMNA | |
| SCHEMBL4841935 | 1.00 | TSHR (0.47) | TSHRCA1CA2CA4LMNA | |
| SCHEMBL2197346 | 1.00 | TSHR (0.47) | TSHRCA1CA2CA4LMNA | |
| SCHEMBL6055449 | 1.00 | TSHR (0.47) | TSHRCA1CA2CA4LMNA | |
| SCHEMBL2196681 | 1.00 | TSHR (0.47) | TSHRCA1CA2CA4LMNA | |
| SCHEMBL2195341 | 1.00 | TSHR (0.47) | TSHRCA1CA2CA4LMNA | |
| SCHEMBL6055429 | 1.00 | TSHR (0.47) | TSHRCA1CA2CA4LMNA | |
| SCHEMBL12641520 | 0.97 | — | — | |
| SCHEMBL4844977 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108290901-A | The preparation method of compound and its subsequent product with ten pentaene skeleton of 16- oxabicyclos [10.3.1] | 巴斯夫欧洲公司 | 2018-07-17 | — | — | CN | claimed |
| EP-1894603-B1 | Encapsulation of bulky fragrance molecules | TAKASAGO PERFUMERY CO LTD (JP) | 2014-11-19 | — | — | EP | claimed |
| US-8609600-B2 | Encapsulation of bulky fragrance molecules | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-12-17 | — | — | US | claimed |
| CN-102048768-B | Preparation method of Naoqing nasal spray emulsion for treating ischemic stroke | UNIV GUANGDONG PHARM | 2012-08-15 | — | — | CN | claimed |
| CN-102048768-A | Preparation method of Naoqing nasal spray emulsion for treating ischemic stroke | UNIV GUANGDONG PHARM | 2011-05-11 | — | — | CN | claimed |
| CN-1899369-A | Heart resurrecting injection preparation and its preparing method | ZHANG HAIFENG (CN) | 2007-01-24 | — | — | CN | claimed |
| EP-1264594-B1 | Melanin production inhibitors and skincare products containing such inhibitors | TAKASAGO PERFUMERY CO LTD (JP) | 2006-11-29 | — | — | EP | claimed |
| CN-1264502-C | Injection of still-freeze drying powder for restoring consciousness and new preparation method | QIN JIXING (CN) | 2006-07-19 | — | — | CN | claimed |
| CN-1686380-A | Peaceful palace bovine bezoar injection and its preparation method | ZHANG HAIFENG (CN) | 2005-10-26 | — | — | CN | claimed |
| CN-1562292-A | Injection of still-freeze drying powder for restoring consciousness and new preparation method | QIN JIXING (CN) | 2005-01-12 | — | — | CN | claimed |
| US-6759557-B2 | MACROCYCLIC HYDROCARBON RINGS WITH HYDROXYL AND/OR KETONE FUNCTIONALITIES, SUCH AS CYCLOTETRADECANONE OR 2-HYDROXYCYCLOHEXADECANONE, OPTIONALLY WITH SKIN WHITENING AGENTS AND/OR UV ABSORBERS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2004-07-06 | — | — | US | claimed |
| US-20030049213-A1 | Melanin production inhibitors and skincare products containing such inhibitors | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2003-03-13 | — | — | US | claimed |
| EP-1264594-A2 | Melanin production inhibitors and skincare products containing such inhibitors | Takasago International Corporation (JP) | 2002-12-11 | — | — | EP | claimed |
| CN-1322568-A | Lung cancer treating medicine | GUO RUILIN (CN) | 2001-11-21 | — | — | CN | claimed |
| CN-1058869-C | Chinese traditional medicine of hair lotion and preparing process | SHI HONGJUN (CN) | 2000-11-29 | — | — | CN | claimed |
| CN-1084760-A | A kind of Chinese medicine hair growth promoter and preparation method thereof | SHI HONGJUN (CN) | 1994-04-06 | — | — | CN | claimed |
| JP-11000189-A | — | — | None | — | — | JP | disclosed |
| US-20250214920-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | KAO CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| CN-1084760-A | A kind of Chinese medicine hair growth promoter and preparation method thereof | SHI HONGJUN (CN) | 1994-04-06 | — | — | CN | disclosed |
| CN-87101921-A | PREPARATION FOR MEDICINAL CIGARETTE | — | 1988-02-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250214920-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | CYP4F2, DUOX1, BCKDK | TSHR 3196/4885CA1 1048/4885CA2 2198/4885 |
| US-20030049213-A1 | Melanin production inhibitors and skincare products containing such inhibitors | TYR, AOC3, DOHH | TSHR 3284/4885CA1 4605/4885CA2 3711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.